Literature DB >> 11960592

Hypertrophic cardiomyopathy: management issues in the new millennium.

Rajesh Thaman1, Sami Firoozi, M S Hamid, William J McKenna.   

Abstract

Hypertrophic cardiomyopathy is an inherited cardiac disorder. Sudden cardiac death frequently occurs in otherwise healthy individuals, and accounts for nearly 35% of all sudden deaths within this age group. Although symptoms occur commonly, they often go unreported. Despite this, a degree of functional limitation is often seen on objective assessment. Management of hypertrophic cardiomyopathy is aimed at relieving symptoms, identifying and treating those individuals at increased risk of sudden death, and screening family members.

Entities:  

Mesh:

Year:  2002        PMID: 11960592     DOI: 10.1007/s11886-002-0055-z

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  41 in total

1.  Late-onset hypertrophic cardiomyopathy caused by a mutation in the cardiac troponin T gene.

Authors:  P M Elliott; L D'Cruz; W J McKenna
Journal:  N Engl J Med       Date:  1999-12-09       Impact factor: 91.245

2.  Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1.

Authors:  J A Jarcho; W McKenna; J A Pare; S D Solomon; R F Holcombe; S Dickie; T Levi; H Donis-Keller; J G Seidman; C E Seidman
Journal:  N Engl J Med       Date:  1989-11-16       Impact factor: 91.245

3.  Hypertrophic cardiomyopathy: role of the implantable cardioverter-defibrillator.

Authors:  J Primo; P Geelen; J Brugada; A L Filho; L Mont; F Wellens; M Valentino; P Brugada
Journal:  J Am Coll Cardiol       Date:  1998-04       Impact factor: 24.094

4.  Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy.

Authors:  H Watkins; A Rosenzweig; D S Hwang; T Levi; W McKenna; C E Seidman; J G Seidman
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

5.  Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle.

Authors:  K Poetter; H Jiang; S Hassanzadeh; S R Master; A Chang; M C Dalakas; I Rayment; J R Sellers; L Fananapazir; N D Epstein
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

6.  Chest pain during daily life in patients with hypertrophic cardiomyopathy: an ambulatory electrocardiographic study.

Authors:  P M Elliott; J C Kaski; K Prasad; H Seo; A K Slade; J H Goldman; W J McKenna
Journal:  Eur Heart J       Date:  1996-07       Impact factor: 29.983

7.  Results of surgery for hypertrophic obstructive cardiomyopathy.

Authors:  W G Williams; E D Wigle; H Rakowski; J Smallhorn; J LeBlanc; G A Trusler
Journal:  Circulation       Date:  1987-11       Impact factor: 29.690

8.  Abnormal vascular responses to supine exercise in hypertrophic cardiomyopathy.

Authors:  P J Counihan; M P Frenneaux; D J Webb; W J McKenna
Journal:  Circulation       Date:  1991-08       Impact factor: 29.690

9.  Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy.

Authors:  R C Robbins; E B Stinson
Journal:  J Thorac Cardiovasc Surg       Date:  1996-03       Impact factor: 5.209

10.  Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis.

Authors:  B J Maron; W H Merrill; P A Freier; K M Kent; S E Epstein; A G Morrow
Journal:  Circulation       Date:  1978-06       Impact factor: 29.690

View more
  2 in total

Review 1.  Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders: Thematic Review Series: Genetics of Human Lipid Diseases.

Authors:  Harjot K Saini-Chohan; Ryan W Mitchell; Frédéric M Vaz; Teresa Zelinski; Grant M Hatch
Journal:  J Lipid Res       Date:  2011-11-07       Impact factor: 5.922

2.  LV twisting and untwisting in HCM: ejection begets filling. Diastolic functional aspects of HCM.

Authors:  Ares Pasipoularides
Journal:  Am Heart J       Date:  2011-11       Impact factor: 4.749

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.